New transplant method aims to tame dangerous side effects in blood cancer patients
NCT ID NCT05565105
Summary
This study is testing a method to process donor stem cells before transplant, aiming to reduce severe complications like graft-versus-host disease (GvHD) and infections. It is for adults (18-74) with certain types of leukemia or lymphoma who need a transplant. The main goal is to see if this processed transplant improves survival and lowers the risk of dangerous side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, MYELOID, ACUTE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baptist Health South Florida/Miami Cancer Institute
Miami, Florida, 33176, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.